CERS250117P3000
- 0.00
- 0.000.00%
Cerus Newsroom
Top SA Quant-rated Medical Devices Stocks as Technicals Look Strong
TD Cowen Maintains Cerus(CERS.US) With Buy Rating, Maintains Target Price $5
TD Cowen Remains a Buy on Cerus (CERS)
Stifel Maintains Cerus(CERS.US) With Buy Rating, Maintains Target Price $3
Positive Growth Outlook and Undervaluation Support Buy Rating for Cerus
Cerus Announces Preliminary 2024 Revenues Of $180.3M, Up 15% From 2023; 2025 Revenue Projected At $194M-$200M, Indicating 8%-11% Growth; IFC Revenue Grows 42% In 2024; 2025 IFC Revenue Predicted Between $12M-$15M; Anticipates LED Illuminator Launch In...
Express News | Cerus Corp: Sees Year-Over-Year Product Revenue Growth for Q1 to Be About 10% to 15%
Cerus Sees 2024 Product Rev $180.3M >CERS
Express News | Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update
Express News | Cerus Outlook FY Revenue USD 194-200 Million
Press Release: Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update
Insider Sale: Director at $CERS (CERS) Sells 20,000 Shares
Express News | Cerus Corp - Extends Supply and Manufacturing Agreement With Porex Until Dec 31, 2027
Cerus And 2 Other US Penny Stocks To Watch
Cerus Corporation to Participate in Upcoming Investor Conferences
ARKK's Holdings Ranked by SA Quant Grades
Does Cerus (NASDAQ:CERS) Have A Healthy Balance Sheet?
Cerus | 10-Q: Q3 2024 Earnings Report
Cerus Shares Are Trading Lower After the Company Reported Mixed Q3 Financial Results.
Q3 2024 Cerus Corp Earnings Call